# MORC3

## Overview
MORC3 (microrchidia family CW-type zinc finger 3) is a gene that encodes a protein involved in chromatin remodeling and gene regulation. The protein, also referred to as MORC family CW-type zinc finger 3, is characterized by a GHKL-type ATPase domain, a CW-type zinc finger domain, and a coiled-coil domain, which collectively facilitate its role in nuclear processes (Li2016Mouse; Zhang2019Mechanism). MORC3 is primarily localized in promyelocytic leukemia nuclear bodies (PML NBs) and is involved in the recruitment and activation of the tumor suppressor protein p53, playing a crucial role in cellular senescence and chromatin organization (Mimura2010Twostep; Takahashi2007Dynamic). The protein's ATPase activity is essential for its function, enabling the formation and diffusion of nuclear domains (Mimura2010Twostep). MORC3's interactions with histone modifications and viral proteins further highlight its significance in chromatin dynamics and immune responses (Zhang2019MORC3; Andrews2016Multivalent). The gene's clinical relevance is underscored by its association with various cancers and autoimmune disorders, where alterations in MORC3 expression or function can impact disease progression and patient prognosis (Andrews2016Multivalent; Wang2021MORC).

## Structure
MORC3 is a protein characterized by several distinct domains that contribute to its function in chromatin remodeling and gene regulation. The primary structure of MORC3 includes a GHKL-type ATPase domain at the N-terminus, which is crucial for ATP binding and hydrolysis, and a CW-type zinc finger domain that acts as an H3K4me reader module, recognizing methylated histone H3 lysine 4 (H3K4me3) (Li2016Mouse; Zhang2019Mechanism). The protein also contains a flexible linker segment and a C-terminal coiled-coil domain, which promotes constitutive dimerization (Li2016Mouse).

The tertiary structure of MORC3 involves the coupling of the ATPase and CW domains, which stabilizes the protein fold but inhibits its catalytic activity. This autoinhibition is relieved when the CW domain binds to the histone H3 tail, allowing the ATPase domain to interact with DNA (Zhang2019Mechanism). The quaternary structure of MORC3 is characterized by ATP-dependent dimerization, which is essential for its function as a molecular clamp for DNA (Li2016Mouse).

Post-translational modifications, such as sumoylation, facilitate MORC3's association with PML nuclear bodies, influencing its role in epigenetic regulation (Li2013The).

## Function
MORC3, also known as NXP2, is a protein that plays a significant role in nuclear processes in healthy human cells. It is part of the microrchidia family and is characterized by a GHL-ATPase domain, a CW-type zinc-finger domain, and a coiled-coil domain (Mimura2010Twostep). MORC3 is primarily localized in promyelocytic leukemia nuclear bodies (PML NBs), where it recruits and activates the tumor suppressor protein p53, a crucial factor for inducing cellular senescence (Mimura2010Twostep; Takahashi2007Dynamic). This activation is essential for the regulation of p53 subnuclear localization and senescence, as MORC3 mediates the recruitment of p53 and CREB-binding protein (CBP) into these structures (Takahashi2007Dynamic).

The ATPase activity of MORC3 is critical for its function, as it facilitates the formation of nuclear domains (NDs) and their diffusion throughout the nucleus (Mimura2010Twostep). MORC3 can form nuclear domains independently of PML, particularly in Pml-deficient cells, through its ATPase cycle, which involves ATP binding and hydrolysis (Mimura2010Twostep). The CW domain of MORC3 is involved in DNA binding or reading the histone code, contributing to its role in chromatin remodeling and gene silencing (Zhang2019Mechanism). SUMOylation of MORC3 is also crucial for its association with PML NBs, although it can still form NDs without PML, indicating a dual role in nuclear organization and protein interactions (Mimura2010Twostep).

## Clinical Significance
Mutations and alterations in the expression of the MORC3 gene are associated with various diseases, including cancer and autoimmune disorders. In cancer, MORC3 is frequently altered, with mutations, amplifications, or deletions observed in bladder, uterine, stomach, and lung cancers, as well as diffuse large B cell lymphomas. These alterations are linked to poorer overall survival in several cancer types, such as sarcoma and acute myeloid leukemia (Andrews2016Multivalent). In head and neck squamous cell carcinoma (HNSCC), lower MORC3 expression is associated with poor survival, while higher expression correlates with longer survival, suggesting a prognostic role (Fu2024Genomewide).

MORC3 is also implicated in autoimmune conditions, particularly idiopathic inflammatory myopathies (IIMs) like polymyositis and dermatomyositis. Anti-MORC3 antibodies serve as myositis-specific autoantibodies, aiding in diagnosis and prognosis. These antibodies are linked to severe disease forms and lower remission rates in juvenile dermatomyositis (Wang2021MORC). In Down syndrome, MORC3 is significantly upregulated, which may contribute to the increased risk of malignancies observed in these patients (Andrews2016Multivalent). The gene's involvement in immune response regulation and chromatin remodeling underscores its clinical significance in these conditions.

## Interactions
MORC3 interacts with various proteins and nucleic acids, playing a significant role in chromatin remodeling and immune response. It is a component of promyelocytic leukemia nuclear bodies (PML NBs) and interacts with PML, Sp100, and hDaxx, influencing their recruitment to viral genomes during infections such as herpes simplex virus 1 (HSV-1) and human cytomegalovirus (HCMV) (Sloan2016MORC3). MORC3 is also involved in the recruitment of Sp100 into PML NBs, although not all PML NB complexes contain detectable levels of MORC3 (Sloan2016MORC3).

The CW domain of MORC3 interacts with histone H3, particularly methylated lysine 4 (H3K4me), which is crucial for its chromatin association and regulation of ATPase activity (Andrews2016Multivalent). This interaction is negatively regulated by the CW domain, which inhibits the ATPase activity by hindering DNA binding (Andrews2016Multivalent).

MORC3 also interacts with viral proteins, such as the influenza A viral protein NS1. The CW domain of MORC3 binds to NS1, with methylation of NS1 enhancing this interaction. This binding potentially alleviates MORC3 autoinhibition and affects its role in the immune response (Zhang2019MORC3).


## References


[1. (Li2016Mouse) Sisi Li, Linda Yen, William A. Pastor, Jonathan B. Johnston, Jiamu Du, Colin J. Shew, Wanlu Liu, Jamie Ho, Bryan Stender, Amander T. Clark, Alma L. Burlingame, Lucia Daxinger, Dinshaw J. Patel, and Steven E. Jacobsen. Mouse morc3 is a ghkl atpase that localizes to h3k4me3 marked chromatin. Proceedings of the National Academy of Sciences, August 2016. URL: http://dx.doi.org/10.1073/pnas.1609709113, doi:10.1073/pnas.1609709113. This article has 40 citations.](https://doi.org/10.1073/pnas.1609709113)

[2. (Andrews2016Multivalent) Forest H. Andrews, Qiong Tong, Kelly D. Sullivan, Evan M. Cornett, Yi Zhang, Muzaffar Ali, JaeWoo Ahn, Ahway Pandey, Angela H. Guo, Brian D. Strahl, James C. Costello, Joaquin M. Espinosa, Scott B. Rothbart, and Tatiana G. Kutateladze. Multivalent chromatin engagement and inter-domain crosstalk regulate morc3 atpase. Cell Reports, 16(12):3195–3207, September 2016. URL: http://dx.doi.org/10.1016/j.celrep.2016.08.050, doi:10.1016/j.celrep.2016.08.050. This article has 41 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.celrep.2016.08.050)

[3. (Zhang2019Mechanism) Yi Zhang, Brianna J. Klein, Khan L. Cox, Bianca Bertulat, Adam H. Tencer, Michael R. Holden, Gregory M. Wright, Joshua Black, M. Cristina Cardoso, Michael G. Poirier, and Tatiana G. Kutateladze. Mechanism for autoinhibition and activation of the morc3 atpase. Proceedings of the National Academy of Sciences, 116(13):6111–6119, March 2019. URL: http://dx.doi.org/10.1073/pnas.1819524116, doi:10.1073/pnas.1819524116. This article has 25 citations.](https://doi.org/10.1073/pnas.1819524116)

[4. (Zhang2019MORC3) Yi Zhang, JaeWoo Ahn, Kelsie J. Green, Kendra R. Vann, Joshua Black, Christopher B. Brooke, and Tatiana G. Kutateladze. Morc3 is a target of the influenza a viral protein ns1. Structure, 27(6):1029-1033.e3, June 2019. URL: http://dx.doi.org/10.1016/j.str.2019.03.015, doi:10.1016/j.str.2019.03.015. This article has 15 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.str.2019.03.015)

[5. (Li2013The) Da-Qiang Li, Sujit S. Nair, and Rakesh Kumar. The morc family: new epigenetic regulators of transcription and dna damage response. Epigenetics, 8(7):685–693, July 2013. URL: http://dx.doi.org/10.4161/epi.24976, doi:10.4161/epi.24976. This article has 75 citations and is from a peer-reviewed journal.](https://doi.org/10.4161/epi.24976)

[6. (Sloan2016MORC3) Elizabeth Sloan, Anne Orr, and Roger D. Everett. Morc3, a component of pml nuclear bodies, has a role in restricting herpes simplex virus 1 and human cytomegalovirus. Journal of Virology, 90(19):8621–8633, October 2016. URL: http://dx.doi.org/10.1128/jvi.00621-16, doi:10.1128/jvi.00621-16. This article has 47 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/jvi.00621-16)

[7. (Mimura2010Twostep) Yasuhiro Mimura, Keiko Takahashi, Kiyo Kawata, Takashi Akazawa, and Norimitsu Inoue. Two-step colocalization of morc3 with pml nuclear bodies. Journal of Cell Science, 123(12):2014–2024, June 2010. URL: http://dx.doi.org/10.1242/jcs.063586, doi:10.1242/jcs.063586. This article has 61 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1242/jcs.063586)

[8. (Fu2024Genomewide) Wenxuan Fu, Xiaomeng Chang, Kun Ye, Zige Zheng, Qianyi Lai, Minyang Ge, and Yan Shi. Genome-wide analysis reveals the morc3-mediated repression of pd-l1 expression in head and neck cancer. Frontiers in Cell and Developmental Biology, September 2024. URL: http://dx.doi.org/10.3389/fcell.2024.1410130, doi:10.3389/fcell.2024.1410130. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fcell.2024.1410130)

[9. (Wang2021MORC) Huan Wang, Ling Zhang, Qiuhua Luo, Jia Liu, and Guiling Wang. Morc protein family-related signature within human disease and cancer. Cell Death &amp; Disease, November 2021. URL: http://dx.doi.org/10.1038/s41419-021-04393-1, doi:10.1038/s41419-021-04393-1. This article has 20 citations.](https://doi.org/10.1038/s41419-021-04393-1)

[10. (Takahashi2007Dynamic) Keiko Takahashi, Naofumi Yoshida, Naoko Murakami, Kiyo Kawata, Hiroyuki Ishizaki, Miki Tanaka-Okamoto, Jun Miyoshi, Andrew R. Zinn, Hiroaki Shime, and Norimitsu Inoue. Dynamic regulation of p53 subnuclear localization and senescence by morc3. Molecular Biology of the Cell, 18(5):1701–1709, May 2007. URL: http://dx.doi.org/10.1091/mbc.e06-08-0747, doi:10.1091/mbc.e06-08-0747. This article has 72 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1091/mbc.e06-08-0747)